# Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria

Study · id `cardio:ct-nct02040441` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02040441](<https://clinicaltrials.gov/study/NCT02040441>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02040441

Browse, organ or system: Kidneys; Metabolism  
Browse, condition area: Diabetes and metabolic disease; Kidney connections  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1777 participants.

## Technical summary

Registry record NCT02040441. Randomized; quadruple masking; primary purpose diagnostic. Start 2014-03 (actual); primary completion 2018-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose diagnostic
- Phase: Phase 2/3
- Enrolled: 1777 participants (enrolled count; ClinicalTrials.gov record NCT02040441, source copy `cardio:ctgov-nct02040441-2018-12-21`, retrieved 2026-10-26)
- Started: 2014-03 (actual) (ClinicalTrials.gov record NCT02040441, source copy `cardio:ctgov-nct02040441-2018-12-21`, retrieved 2026-10-26)
- Primary completion: 2018-11 (actual) (ClinicalTrials.gov record NCT02040441, source copy `cardio:ctgov-nct02040441-2018-12-21`, retrieved 2026-10-26)
- Completion: 2018-11 (actual) (ClinicalTrials.gov record NCT02040441, source copy `cardio:ctgov-nct02040441-2018-12-21`, retrieved 2026-10-26)
- Countries: Belgium; Czechia; Denmark; Germany; Greece; Italy; Netherlands; North Macedonia; Spain; United Kingdom (ClinicalTrials.gov record NCT02040441, source copy `cardio:ctgov-nct02040441-2018-12-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02040441-2018-12-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
- Acronym: PRIORITY
- Condition: Diabetic Nephropathy
- Condition: Diabetic Retinopathy
- Intervention (Drug): Spironolactone
- Intervention (Drug): Placebo
- Intervention (Drug): Standard care
- Lead sponsor: Peter Rossing
- Lead sponsor class: OTHER
- Collaborator: Mosaiques Diagnostics GmbH
- Collaborator class: UNKNOWN
- Collaborator: University Medical Center Groningen
- Collaborator class: OTHER
- Collaborator: University of Glasgow
- Collaborator class: OTHER
- Collaborator: Istituto Di Ricerche Farmacologiche Mario Negri
- Collaborator class: OTHER
- Collaborator: Univerzita Karlova v Praze
- Collaborator class: OTHER
- Collaborator: Geniko Nosokomeio Athinas Ippokrateio
- Collaborator class: UNKNOWN
- Collaborator: Institut Klinické a Experimentální Mediciny Praze
- Collaborator class: UNKNOWN
- Collaborator: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
- Collaborator class: OTHER
- Collaborator: Klinikum St. Georg Leipzig
- Collaborator class: UNKNOWN
- Collaborator: Ss. Cyril and Methodius University of Skopje
- Collaborator class: OTHER
- Collaborator: Hannover Clinical Trial Center
- Collaborator class: UNKNOWN
- Collaborator: European Commission
- Collaborator class: OTHER
- Collaborator: Diabetes Vascular Research Foundation Hoogeveen
- Collaborator class: UNKNOWN
- Collaborator: University Ghent
- Collaborator class: OTHER
- Collaborator: Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden
- Collaborator class: UNKNOWN
- Collaborator: Stichting VUMC
- Collaborator class: UNKNOWN
- Collaborator: Diabetologen Hessen
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry condition terms include this condition: Diabetic kidney disease (`cardio:diabetic-nephropathy`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry lists this organization as the lead sponsor: Peter Rossing (`cardio:org-peter-rossing`)
- Registry lists this organization as a collaborator: University Medical Center Groningen (`cardio:org-university-medical-center-groningen`)
- Registry lists this organization as a collaborator: University of Glasgow (`cardio:org-university-of-glasgow`)
- Registry lists this organization as a collaborator: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (`cardio:org-instituto-de-investigacion-sanitaria-de-la-fundacion-8312e5`)
- Registry lists this organization as a collaborator: European Commission (`cardio:org-european-commission`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria - A post-hoc analysis of the PRIORITY randomized clinical trial (`cardio:pubmed-36841085`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 20cbf5d789c30162113a073eb1fc14f2e3e5b9f4bd17acdf41f51ccccba08f97
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
